5-8 November 2026 Brussels
| 3-O | Perirenal shell morphology separates renal pelvis upper tract urothelial carcinoma from renal cell carcinoma beyond tumour size alone | Ali Alshehri | |
| 54-P | Moderate hypofrakcionation in elective pelvic nodal irradiation improves radiographic disease control without increasing late toxicity in high risk localised prostate cancer: RADIANCE trial | Martin Palkovsky | |
| 95-P | The Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Marker of Response in Patients with Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC) | Kiril Zhelev | |
| 114-P | PSMA PET/CT-guided treatment intensification with 18F-DCFPyL in biochemically recurrent prostate cancer | SARA SEIJAS MARCOS | |
| 206-P | Model-generated decision-domain profiles of ChatGPT treatment recommendations in localised muscle-invasive bladder cancer | Eduardo Felício | |
| 215-P | Bladder preservation vs radical cystectomy in muscle-invasive bladder cancer: Prospective clinicopathological and survival outcomes | Ali Shamseddine | |
| 216-P | Redesigning Bladder cancer pathways: Clinical safety, financial savings, and carbon reduction of a surgeon-led day-case TURBT model | Ashwini Gaur | |
5-8 November 2026 Brussels

Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. |
||||
|
|